%0 Journal Article
%T Dual antiplatelet therapy versus aspirin monotherapy in diabetics with stable ischemic heart disease undergoing coronary artery bypass grafting
%A Abeel A. Mangi
%A Arnar Geirsson
%A James J. Yun
%A Kayoko Shioda
%A Makoto Mori
%A Syed Usman Bin Mahmood
%J Archive of "Annals of Cardiothoracic Surgery".
%D 2018
%R 10.21037/acs.2018.08.01
%X Dual antiplatelet therapy (DAPT) in patients presenting with acute coronary syndrome (ACS) undergoing CABG is recommended to prevent recurrent ischemic events. The benefit of DAPT post-CABG in patients with stable ischemic heart disease (SIHD) is unknown. The aim of this study was to evaluate the utilization rate of DAPT and associated outcomes in patients with SIHD undergoing CABG via a secondary analysis of Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial data
%K Dual antiplatelet therapy (DAPT)
%K coronary artery bypass grafting (CABG)
%K Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)
%K stable ischemic heart disease (SIHD)
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219944/